Literature DB >> 22861805

The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain.

Fergus Shanahan1.   

Abstract

Ulcerative colitis and Crohn's disease, collectively known as inflammatory bowel disease, represent the heterogeneous outcome of three colliding influences: genetic risk factors, environmental modifiers, and immune effector mechanisms of tissue injury. The nature of these inputs is complex, with each having distinct and overlapping contributions to ulcerative colitis and Crohn's disease. Identification of specific genetic risk factors has improved the understanding of specific pathways to disease, but the primacy of environmental or lifestyle factors linked to changes in the gut microbiota, particularly in early life, is increasingly evident. Clarification of the molecular basis of host-microbe interactions in health and in susceptible individuals promises novel therapeutic strategies.
© 2012 International Life Sciences Institute.

Entities:  

Mesh:

Year:  2012        PMID: 22861805     DOI: 10.1111/j.1753-4887.2012.00502.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  9 in total

Review 1.  Characterization of inflammatory bowel disease in elderly patients: A review of epidemiology, current practices and outcomes of current management strategies.

Authors:  Peter Stepaniuk; Charles N Bernstein; Laura E Targownik; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-12

2.  Microbiology: Microbiome science needs a healthy dose of scepticism.

Authors:  William P Hanage
Journal:  Nature       Date:  2014-08-21       Impact factor: 49.962

3.  Gut bacteria in health and disease.

Authors:  Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-09

4.  Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation.

Authors:  Nitsan Maharshak; Christopher D Packey; Melissa Ellermann; Sayeed Manick; Jennica P Siddle; Eun Young Huh; Scott Plevy; R Balfour Sartor; Ian M Carroll
Journal:  Gut Microbes       Date:  2013-06-20

5.  Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ.

Authors:  Caitriona M Guinane; Paul D Cotter
Journal:  Therap Adv Gastroenterol       Date:  2013-07       Impact factor: 4.409

6.  Mild clinical behaviour of Crohn disease in elderly patients in a Latin American country: A case-control study.

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar
Journal:  Can J Gastroenterol Hepatol       Date:  2015-05-21

Review 7.  The Natural Antimicrobial Enzyme Lysozyme is Up-Regulated in Gastrointestinal Inflammatory Conditions.

Authors:  Carlos A Rubio
Journal:  Pathogens       Date:  2014-01-16

Review 8.  Associations between Folate and Vitamin B12 Levels and Inflammatory Bowel Disease: A Meta-Analysis.

Authors:  Yun Pan; Ya Liu; Haizhuo Guo; Majid Sakhi Jabir; Xuanchen Liu; Weiwei Cui; Dong Li
Journal:  Nutrients       Date:  2017-04-13       Impact factor: 5.717

Review 9.  The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.

Authors:  Anthony P Corfield
Journal:  Microorganisms       Date:  2018-08-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.